Suchergebnisse - "Reyes, Roxana"

PubPharm (6)

1

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Auclin, E. | Benitez-Montanez, J. | Tagliamento, M. | +24

2

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe : results from the retrospective, multicentre, OnCovid registry study

enthalten in: The Lancet. Oncology | 2022

von Pinato, D. | Aguilar-Company, J. | Ferrante, D. | +147

3

Time-Dependent COVID-19 Mortality in Patients With Cancer : An Updated Analysis of the OnCovid Registry

enthalten in: JAMA oncology | 2022

von OnCovid Study Group | Pinato, D. | Patel, M. | +78

4

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection : evidence from the OnCovid retrospective, multicentre registry study

enthalten in: The Lancet. Oncology | 2021

von Pinato, D. | Tabernero, J. | Bower, M. | +130

5

Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC) : The pluie study

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Epaillard, N. | Benitez, J. | Gorria, T. | +10

6

Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection : the OnCovid Inflammatory Score

enthalten in: Journal for immunotherapy of cancer | 2021

von Dettorre, G. | Dolly, S. | Loizidou, A. | +59

ErratumIn: J Immunother Cancer. 2021 Jun;9(6):. - PMID 34135105

1
[1]